Docetaxel
Links shared publicly online about this topic
Oncology Medical News about Docetaxel
mdlinx.com — “Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 2:03 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study: Anti-Cancer Drugs http://bit.ly/cjquYl
Lancet: Chemo w/ docetaxel improves survival
healthimaging.com — “The addition of docetaxel to an induction chemotherapy regiment in patients with locally advanced head and neck cancer improved five-year survival rates from 42 percent to 52 percent and nearly doubled median survival time, leading researchers to recommend the three-drug regiment for eligible patients, with the findings published Jan. 12 in The Lancet Oncology.” View full resource at healthimaging.com
Most Recently Shared on January 12, 2011 at 2:31 pm By:
Health Imaging & IT Health Magazine
Lancet: Chemo w/ docetaxel improves survival - The addition of docetaxel to an induction chemotherapy regiment in pa... http://ow.ly/1aPOb7
Mylan S.A.S. Withdraws Its Marketing Authorisation Application For Docetaxel Mylan (docetaxel), Europe
medicalnewstoday.com — “The European Medicines Agency has been formally notified by Mylan S.A.S. of its decision to withdraw its application for a centralised marketing authorisation for the medicinal product Docetaxel M” View full resource at medicalnewstoday.com
Most Recently Shared on March 16, 2010 at 12:21 pm By:
Mylan S.A.S. Withdraws Its Marketing Authorisation Application For Docetaxel Mylan (docetaxel), Europe http://mnt.to/3yVZ #cancer
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial " Ann Oncol
annonc.oxfordjournals.org — “Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial " Ann Oncol” View full resource at annonc.oxfordjournals.org
Most Recently Shared on October 12, 2009 at 2:45 pm By:
J Nat'l Cancer Inst Oncology and Medical Journal
RT @Annals_Oncology Open Access: Docetaxel v docetaxel alternating w/ gemcitabine as treatments of advan. breast cancer http://bit.ly/1AXG1H
45% Of Breast Tumors Destroyed With Pertuzumab And Herceptin Combo Plus Chemotherapy Docetaxel
medicalnewstoday.com — “45% of women with pre-surgery early-stage HER2-positive breast cancer experienced a complete tumor reduction when given Pertuzumab and Herceptin plus chemotherapy (docetaxel) during a Phase II stu” View full resource at medicalnewstoday.com
Most Recently Shared on December 10, 2010 at 8:24 pm By:
45% Of Breast Tumors Destroyed With Pertuzumab And Herceptin Combo Plus Chemotherapy Docetaxel http://mnt.to/3NX3 #healthnews
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
drugs.com — “Docefrez (docetaxel) is used to treat metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer. Includes Docefrez side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 4, 2011 at 11:19 pm By:
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection - http://bit.ly/kreMHf
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection
drugs.com — “Docefrez (docetaxel) is used to treat metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer. Includes Docefrez side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:12 am By:
Drugs and Devices OW OW Health
Sun Pharma Announces US FDA Approval for Docefrez (docetaxel) for Injection: Mumbai, May 4, 2011: Sun Phar... http://bit.ly/jq8d86 #drug
FDA Approves Generic Docetaxel Injection from Hospira - ONA
oncologynurseadvisor.com — “The FDA has approved a single-vial formulation of docetaxel injection from Hospira, a generic version of Taxotere (sanofi-aventis).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 10, 2011 at 3:46 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA Approves Generic Docetaxel Injection from Hospira http://goo.gl/fb/h3fnK
FDA Approves Generic Docetaxel Injection from Hospira - MPR
empr.com — “The FDA has approved a single-vial formulation of docetaxel injection from Hospira, a generic version of Taxotere (sanofi-aventis).” View full resource at empr.com
Most Recently Shared on March 10, 2011 at 3:53 pm By:
MPR News: FDA Approves Generic Docetaxel Injection from Hospira: The FDA has approved a single-vial formulation ... http://bit.ly/iiOSPR
Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC
news-medical.net — “Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.” View full resource at news-medical.net
Most Recently Shared on November 23, 2011 at 6:35 am By:
Cancer News Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC: Celgene I... http://t.co/rlNlXldU
U.S. FDA approves Hospira's docetaxel to treat variety of cancers
news-medical.net — “Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere, and Hospira expects to launch the product later this month.” View full resource at news-medical.net
Most Recently Shared on March 10, 2011 at 5:42 am By:
News-Medical.Net Oncology and Health News
Oncology News: U.S. FDA approves Hospira's docetaxel to treat variety of cancers: Hospira, Inc., the world leade... http://bit.ly/fZkkTS
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
physorg.com — “When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.” View full resource at physorg.com
Most Recently Shared on June 1, 2009 at 2:24 pm By:
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer http://tinyurl.com/lqswv2
Docetaxel Slows PSA Progression in Metastatic Prostate Cancer : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on February 23, 2011 at 11:50 pm By:
Docetaxel Slows PSA Progression in Metastatic Prostate Cancer http://bit.ly/gyAKb6
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer - News
virtualmedicalcentre.com — “When combined with standard chemotherapy, the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer.” View full resource at virtualmedicalcentre.com
Most Recently Shared on June 21, 2010 at 2:09 pm By:
VirtualMedicalCentre Health Site
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer http://dlvr.it/1vTQF
UroToday - Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: A retrospective multicentre study - Abstract
urotoday.com — “Breaking Urology news written by Urologists for Urologists. Global leaders in Urology provide key conference report coverage and daily articles on top urology headlines.” View full resource at urotoday.com
Most Recently Shared on March 30, 2010 at 7:41 am By:
Docetaxel reintroduction in patients with metastatic castration-resistant ... http://bit.ly/da9ZVd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Health Imaging & IT
Health Imaging & IT | Images, Information & Knowledge Across the Enterprise
-
MNT Cancer News
The latest cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
